RA
MDT icon

Royce & Associates’s Medtronic MDT Stock Holding History

Royce & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-66,100
Closed -$4.21M – 1423
2014
Q2 		$4.21M Sell
66,100
-62,700
-49% -$3.81M 0.01% 897
2014
Q1 		$7.93M Sell
128,800
-4,400
-3% -$256K 0.02% 756
2013
Q4 		$7.64M Buy
133,200
+20,400
+18% +$1.16M 0.02% 762
2013
Q3 		$6.01M Buy
112,800
+20,900
+23% +$1.12M 0.02% 804
2013
Q2 		$4.73M Buy
+91,900
New +$4.54M 0.01% 859

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royce & Associates's MDT Position: Q3 2014 in Review

Royce & Associates sold out of Medtronic (MDT) in Q3 2014, closing a stake of 66,100 shares — an estimated $4.21M sold.

Royce & Associates first reported a position in MDT in Q2 2013 and held it in 5 quarters. The position peaked at $7.93M in Q1 2014. 1,136 funds tracked by Wall St. Rank hold MDT as of Q3 2014.

  • Royce & Associates reported no remaining Medtronic position as of Q3 2014 after selling out during the quarter.
  • Royce & Associates sold 66,100 Medtronic shares in Q3 2014, an estimated $4.21M.
  • Royce & Associates first reported a position in Medtronic in Q2 2013 and held it in 5 quarters.
  • Royce & Associates's Medtronic position peaked at $7.93M in Q1 2014.
  • 1,136 funds tracked by Wall St. Rank held Medtronic as of Q3 2014.

Based on Royce & Associates's 13F filing for Q3 2014, filed 12 Nov 2014.